<DOC>
	<DOCNO>NCT01466634</DOCNO>
	<brief_summary>Evidence support use bioabsorbable polymer drug elute stent ( BP-DES ) uncertain . Thus investigator plan meta-analysis compare outcomes BP-DES versus PP-DES obstructive coronary artery disease .</brief_summary>
	<brief_title>Bioabsorbable Versus Durable Polymer Drug Eluting Stent ( DES ) : Meta-analysis</brief_title>
	<detailed_description>Evidence support use bioabsorbable polymer drug elute stent ( BP-DES ) uncertain . Previous study suggest BP-DES least effective durable polymer drug elute stent ( PP-DES ) . Thus investigator plan meta-analysis compare outcomes BP-DES versus PP-DES obstructive coronary artery disease . Medline Web databases searched study compare BP-DES PP-DES obstructive coronary disease , report rate overall mortality , target lesion revascularization ( TLR ) , myocardial infarction ( MI ) , binary restenosis late lumen loss ( LLL ) follow-up â‰¥ 6 month . Odds ratio ( ORs ) compute individual study pool accord fix effect ( e.g . inverse variance weight ) random effect model case statistical heterogeneity . Given priori heterogeneous nature observational analysis , separate subgroup analysis study PLA bioabsorbable polymer load biolimus A19 ( BP-BES ) prespecified .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>randomize study study report clinical outcome overall death and/or acute myocardial infarction and/or late stent thrombosis ( ARC definition ) [ ** ] and/or target lesion revascularization and/or late lumen loss follow period longer 6 month . duplicate reporting ( case manuscript report large sample long followup select ) inability compute risk estimate due absence clinical event one group study present composite major adverse cardiac event ( MACE ) individual end point .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>